Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1 Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02239835
What this trial is testing

Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 79
Not applicableStudy completedNCT00259389
What this trial is testing

Directly Observed Therapy for HIV Infected Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT05140876
What this trial is testing

Supporting Treatment Adherence for Resilience and Thriving (START)

Who this might be right for
Adherence, MedicationHIV-1-infectionStimulant Use
Florida International University 286
Not applicableStudy completedNCT00390949
What this trial is testing

Scientific Evaluation of Peer Education and STD Treatment to Reduce the Spread of HIV in Zimbabwe

Who this might be right for
HIV Infections
Imperial College London 9,454
Large-scale testing (Phase 3)Study completedNCT00524368
What this trial is testing

Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)

Who this might be right for
Human Immunodeficiency Virus - Type 1
Tibotec Pharmaceuticals, Ireland 590
Testing effectiveness (Phase 2)Study completedNCT01734850
What this trial is testing

Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

Who this might be right for
Human Immunodeficiency Virus
Calimmune, Inc. 13
Not applicableLooking for participantsNCT04174755
What this trial is testing

Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV

Who this might be right for
ObesityHIV-1-infection
University College Dublin 80
Not applicableStudy completedNCT01906255
What this trial is testing

Adherence, HIV-1 Infection, Resistance, and Renal and Skeletal Adverse Event in Individuals Taking Truvada® for HIV Pre-Exposure Prophylaxis (PrEP)

Who this might be right for
HIV
Gilead Sciences 10,577
Early research (Phase 1)Study completedNCT01950325
What this trial is testing

VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...

Who this might be right for
HIV-1 InfectionNeutralizing AntibodyMonoclonal Antibody+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 27
Large-scale testing (Phase 3)Study completedNCT00002389
What this trial is testing

The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Glaxo Wellcome 210
Not applicableStudy completedNCT01436136
What this trial is testing

Reducing Cardiovascular Disease (CVD) Risk in HIV on Antiretroviral Therapy Over 12 Months

Who this might be right for
HIV-1 InfectionCardiovascular Disease
Holdsworth House Medical Practice 92
Early research (Phase 1)Study completedNCT00083330
What this trial is testing

Safety and Immunogenicity of an HIV Vaccine in Normal Adult Volunteers

Who this might be right for
HealthyHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT00000663
What this trial is testing

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Very early researchStudy completedNCT06541093
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.

Who this might be right for
AIDS/HIV - RelatedDisease Associated With AIDSVaccine-Preventable DiseasesHIV Infections
Uvax Bio LLC 34
Early research (Phase 1)Study completedNCT00712530
What this trial is testing

Single DermaVir Immunization in HIV-1 Infected Patients on HAART

Who this might be right for
HIV Infection
Genetic Immunity 9
Large-scale testing (Phase 3)UnknownNCT02231281
What this trial is testing

Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults

Who this might be right for
Acute HIV Infection
Yongtao Sun, MD, PhD 65
Early research (Phase 1)Study completedNCT04424264
What this trial is testing

The Effect of Rifampicin on the Pharmacokinetics of Intracellular Tenofovir-diphosphate and Tenofovir When Coadministered With Tenofovir Alafenamide Fumarate During the Maintenance Phase of Tuberculosis Treatment in TB/HIV-1 Coinfected Participants

Who this might be right for
HIV-1-infectionTuberculosis
Professor Francois Venter 18
Large-scale testing (Phase 3)Looking for participantsNCT07071623
What this trial is testing

MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

Who this might be right for
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Merck Sharp & Dohme LLC 4,580
Testing effectiveness (Phase 2)Study completedNCT01565850
What this trial is testing

D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 153
Not applicableNot Yet RecruitingNCT07569913
What this trial is testing

Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test

Who this might be right for
HIV1 InfectionHIV 2 InfectionSyphilis Infection+1 more
bioLytical Laboratories 500
Next Page